Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study

OBJECTIVE: The purpose of this study was to investigate the efficacy and tolerability of atypical antipsychotics (AAPs) with augmentation by blonanserin in schizophrenic patients. METHODS: aA total of 100 patients with schizophrenia who were partially or completely unresponsive to treatment with an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Psychiatry Investig
Glavni autori: Woo, Young Sup, Park, Joo Eon, Kim, Do-Hoon, Sohn, Inki, Hwang, Tae-Yeon, Park, Young-Min, Jon, Duk-In, Jeong, Jong-Hyun, Bahk, Won-Myong
Format: Artigo
Jezik:Inglês
Izdano: Korean Neuropsychiatric Association 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965658/
https://ncbi.nlm.nih.gov/pubmed/27482249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2016.13.4.458
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items